Core Alternative Capital Danaher Corp Transaction History

Core Alternative Capital

$498 Million
Q3 2024

A detailed history of Core Alternative Capital transactions in Danaher Corp stock. As of the latest transaction made, Core Alternative Capital holds 2,422 shares of DHR stock, worth $571,204. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,422

Previous 2,422 -0.0%

Holding current value

$571,204

Previous $605,000 11.24%

% of portfolio

0.14%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	SELL	$235.51 - $267.98 $6,594 - $7,503	-28 Reduced 1.14%	2,422 $605,000
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $2,919 - $3,330	-13 Reduced 0.53%	2,450 $611,000
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $196,206 - $247,117	-1,060 Reduced 30.09%	2,463 $569,000
Q3 2023 Oct 19, 2023	SELL	$233.08 - $265.59 $318,154 - $362,530	-1,365 Reduced 27.93%	3,523 $874,000
Q2 2023 Jul 27, 2023	BUY	$224.99 - $256.14 $67,721 - $77,098	301 Added 6.56%	4,888 $1.17 Million
Q1 2023 Apr 18, 2023	SELL	$239.75 - $277.0 $145,768 - $168,416	-608 Reduced 11.7%	4,587 $1.16 Million
Q4 2022 Jan 31, 2023	BUY	$241.42 - $282.29 $103,327 - $120,820	428 Added 8.98%	5,195 $1.38 Million
Q3 2022 Oct 18, 2022	BUY	$247.06 - $1507.4 $201,848 - $1.23 Million	817 Added 20.68%	4,767 $1.23 Million
Q2 2022 Aug 01, 2022	BUY	$237.11 - $299.66 $324,603 - $410,234	1,369 Added 53.04%	3,950 $1 Million
Q1 2022 May 10, 2022	BUY	$257.27 - $315.76 $478,007 - $586,682	1,858 Added 256.98%	2,581 $757,000
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $190,436 - $214,514	652 Added 918.31%	723 $238,000
Q3 2021 Nov 05, 2021	BUY	$272.21 - $332.43 $19,326 - $23,602	71 New	71 $22,000

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Danaher Corp Transaction History